Literature DB >> 8875257

The factor IX gene as a model for analysis of human germline mutations: an update.

S S Sommer1, R P Ketterling.   

Abstract

The variation generated by germline mutation is essential for evolution, but individuals pay a steep price in the form of Mendelian disease and genetic predisposition to complex disease. Indeed, the health of a species is determined ultimately by the rate of germline mutation. Analysis of the factor IX gene in patients with hemophilia B has provided insights into the human germline mutational process. Herein, seven topics will be reviewed with emphasis on recent advances: (i) proposed mechanisms of deletions, inversions, and insertions; (ii) discordant sex ratios of mutation and associated age effects; (iii) somatic mosaicism; (iv) founder effects; (v) mutation rates; (vi) the factor IX gene as a germline mutagen test; and (vii) cancer as a possible mechanism for maintaining a constant rate of germline mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875257     DOI: 10.1093/hmg/5.supplement_1.1505

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Estimate of the mutation rate per nucleotide in humans.

Authors:  M W Nachman; S L Crowell
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

Review 2.  Measurements of spontaneous rates of mutations in the recent past and the near future.

Authors:  Fyodor A Kondrashov; Alexey S Kondrashov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-27       Impact factor: 6.237

3.  An excess of G over C nucleotides in mutagenesis of human genetic diseases.

Authors:  Li Xiao; Wanping Sun; Jia Zhang; Yanping Zhou; Linling Chen; Hanlin Gao; Pierre Sirois; Kai Li
Journal:  Mol Biotechnol       Date:  2011-05       Impact factor: 2.695

4.  Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.

Authors:  F Giannelli; T Anagnostopoulos; P M Green
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

5.  High resolution melting for F9 gene mutation analysis in patients with haemophilia B.

Authors:  Roberta Salviato; Donata Belvini; Paolo Radossi; Giuseppe Tagariello
Journal:  Blood Transfus       Date:  2018-02-28       Impact factor: 3.443

6.  Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease.

Authors:  C Mimault; G Giraud; V Courtois; F Cailloux; J Y Boire; B Dastugue; O Boespflug-Tanguy
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

7.  Methylation levels at selected CpG sites in the factor VIII and FGFR3 genes, in mature female and male germ cells: implications for male-driven evolution.

Authors:  O El-Maarri; A Olek; B Balaban; M Montag; H van der Ven; B Urman; K Olek; S H Caglayan; J Walter; J Oldenburg
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

8.  Mutation analysis of a cohort of US patients with hemophilia B.

Authors:  Tengguo Li; Connie H Miller; Jennifer Driggers; Amanda B Payne; Dorothy Ellingsen; W Craig Hooper
Journal:  Am J Hematol       Date:  2014-03-03       Impact factor: 10.047

9.  The influence of genomic context on mutation patterns in the human genome inferred from rare variants.

Authors:  Valerie M Schaibley; Matthew Zawistowski; Daniel Wegmann; Margaret G Ehm; Matthew R Nelson; Pamela L St Jean; Gonçalo R Abecasis; John Novembre; Sebastian Zöllner; Jun Z Li
Journal:  Genome Res       Date:  2013-08-29       Impact factor: 9.043

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.